UPDATE: Raymond James Downgrades Viking Therapeutic (VKTX) to Outperform

Go back to UPDATE: Raymond James Downgrades Viking Therapeutic (VKTX) to Outperform
ING Van Kampen Equity Growth Fund S 2 Class (NASDAQ: VKTX) Delayed: 32.94 --0 (-0%)
Previous Close $32.94    52 Week High $5.17 
Open $32.94    52 Week Low $0.94 
Day High $32.94    P/E N/A 
Day Low $32.94    EPS $0.00 
Volume 4,672